🔗 Share this article

The top legal official in Texas Ken Paxton is taking legal action against the manufacturers of acetaminophen, asserting the companies concealed safety concerns that the pain reliever created to pediatric brain development.

The court filing follows four weeks after Former President Trump advocated an unverified association between consuming acetaminophen - alternatively called paracetamol - during pregnancy and autism in offspring.

The attorney general is filing suit against Johnson & Johnson, which formerly manufactured the medication, the only pain reliever approved for expectant mothers, and the current manufacturer, which presently makes it.

In a official comment, he claimed they "betrayed America by profiting off of suffering and pushing pills regardless of the dangers."

The manufacturer says there is lacking scientific proof connecting Tylenol to autism spectrum disorder.

"These corporations lied for decades, deliberately risking numerous people to increase profits," Paxton, a Republican, stated.

The manufacturer stated officially that it was "deeply concerned by the dissemination of inaccurate information on the reliability of acetaminophen and the possible consequences that could have on the health of American women and children."

On its official site, the company also said it had "consistently assessed the relevant science and there is lacking reliable evidence that indicates a established connection between using paracetamol and autism spectrum disorder."

Organizations representing medical professionals and health professionals concur.

The leading OB-GYN organization has said acetaminophen - the key substance in acetaminophen - is one of the few options for expectant mothers to address pain and elevated temperature, which can pose significant medical dangers if ignored.

"In more than two decades of studies on the use of paracetamol in pregnancy, no reliable research has successfully concluded that the usage of paracetamol in any stage of pregnancy results in neurodevelopmental disorders in offspring," the organization stated.

This legal action cites latest statements from the former administration in claiming the drug is allegedly unsafe.

Recently, the former president generated worry from medical authorities when he instructed women during pregnancy to "resist strongly" not to take Tylenol when unwell.

The FDA then issued a notice that medical professionals should contemplate reducing the consumption of Tylenol, while also stating that "a proven link" between the medication and autism spectrum disorder in children has remains unverified.

The Health Department head RFK Jr, who manages the FDA, had vowed in spring to initiate "comprehensive study program" that would determine the cause of autism spectrum disorder in a short period.

But experts warned that identifying a unique factor of autism - thought by researchers to be the consequence of a complicated interplay of genetic and external influences - would not be simple.

Autism spectrum disorder is a type of permanent neurological difference and disability that impacts how persons perceive and relate to the surroundings, and is recognized using medical professional evaluations.

In his lawsuit, the attorney general - aligned with the former president who is running for federal office - claims Kenvue and J&J "deliberately disregarded and sought to suppress the research" around paracetamol and autism spectrum disorder.

The case aims to force the firms "destroy any commercial messaging" that states Tylenol is safe for pregnant women.

This legal action echoes the grievances of a assembly of guardians of children with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the producers of acetaminophen in recently.

The court dismissed the legal action, saying studies from the parents' expert witnesses was inconclusive.